SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-22-067095
Filing Date
2022-06-01
Accepted
2022-06-01 16:00:15
Documents
1
Group Members
SAMSARA BIOCAPITAL GP, LLCSRINIVAS AKKARAJU

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2217378d1_sc13d.htm SC 13D 90581
  Complete submission text file 0001104659-22-067095.txt   92306
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Subject) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88812 | Film No.: 22987245
SIC: 2834 Pharmaceutical Preparations

Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301 (650) 285-4270
Samsara BioCapital, L.P. (Filed by) CIK: 0001699737 (see all company filings)

IRS No.: 813958301 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D